EUDA Health Holdings Limited

NASDAQ:EUDA

Medical - Care Facilities

Healthcare
$17.70 +14.19%

+$2.20 today

Market cap
$53.00M
Beta
0.59
P/E (TTM)
-7.9
EPS (TTM)
-$1.79
52W Low $5.26High $71.20

Volume 0.04M

Average 0.02M

EUDA Interest Expense

Cost of servicing the company's debt during the period.

EUDA Health Holdings LimitedNASDAQ: EUDA

Interest Expense · Q2 FY2026 · quarter ended Jun 2026

Interest expense remains negative

Q2 FY2026 interest expense was $0, compared with $21.83K a year earlier. Trailing-twelve-month interest expense was $321.11K. Over 3 fiscal years it compounded at +34.6% a year.

Context

  • Interest expense amounted to 3.4% of revenue in FY2025, up 2.2 pp from a year earlier.
  • Interest expense increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly interest expense holds near $0 or moves back toward the trailing-twelve-month quarterly average of $80.28K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$228.62K+409.3% YoY
LTMJun 2026
$321.11K+604.4% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year+409.3%——
3-year CAGR+34.6%——
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
228.62K USD
Year-over-year change
+409.3%
4-year CAGR
+15.8%

Interest Expense vs competitors

How EUDA compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +604.4% is the highest of 4, against a peer median of -11.7%.
  • Interest expense amounts to 2.6% of revenue for EUDA, versus a peer median of 0.3%.
EUDA Competitors
Interest Expense for EUDA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DTILPrecision BioSciences, Inc.LTM Mar 2026$1.38M USD-11.7%+8.6%3.1%
EUDAEUDA Health Holdings LimitedLTM Jun 2026$321.11K USD+604.4%+34.6%2.6%
ZTEKZentek Ltd.LTM Mar 2026CA$269.6K CAD-1.2%+34.0%162.3%
HYPRHyperfine, Inc.LTM Mar 2026$83K USD——0.5%
FONRFONAR CorporationLTM Mar 2026$12.61K USD-59.3%-58.0%0.0%
AMWLAmerican Well CorporationLTM Mar 2026$0 USD——0.0%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD———
ATYRaTyr Pharma, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding EUDA) —-11.7%+8.6%0.3%

Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.56M3.76M3.71M4.01M6.82M
Cost of Revenue3.31M2.89M2.86M3.25M3.83M
Gross Profit1.25M870K842.08K762.16K2.99M
Gross Margin27.4%23.1%22.7%19.0%43.9%
Research & Development129.27K17.21K00249
Selling, General & Admin1.81M6.75M4.8M3.34M5.43M
Operating Expenses1.81M13.09M4.8M18.1M5.43M
Depreciation & Amortization264.1K172.02K119.35K173.22K406.48K
EBITDA1.34M(24.64M)(8.29M)(17.42M)(2.09M)
EBITDA Margin29.4%-654.6%-223.7%-434.4%-30.7%
Operating Income(559.99K)(5.72M)(3.96M)(17.34M)(2.44M)
Operating Margin-12.3%-151.9%-106.9%-432.2%-35.8%
Interest Income1.92M0000
Interest Expense127.13K93.78K23.23K44.89K228.62K
Other Income / Expenses2.23M(19.21M)(4.47M)(307.38K)(285.26K)
Income Before Tax1.67M(24.93M)(8.43M)(17.64M)(2.73M)
Pre-Tax Margin36.6%-662.3%-227.6%-439.8%-40.0%
Income Tax Expense46.49K(20.79K)0(4.38K)41.94K
Net Income864.83K(24.88M)(10.04M)(15.36M)(2.77M)
Net Margin19.0%-661.1%-270.9%-382.9%-40.7%
EPS (Basic)1.87(41.40)(8.80)(9.40)(1.49)
EPS (Diluted)1.87(41.40)(8.80)(9.40)(1.49)
Weighted Avg Shares462.67K601.48K1.15M1.62M1.86M
Weighted Avg Shares (Diluted)462.67K601.48K1.15M1.62M1.86M

EUDA Health Holdings Limited

NASDAQ:EUDA

Intrinsic Alpha fair value

Locked

Current Price

$17.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.